Several Readouts on Allogeneic Cell Therapy Expected in 2020
March 20, 2020
Prasad, Raju
Outperforming Over a Full Market Cycle with Less Volatility
December 13, 2019
Benowitz, Jason
Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha
Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola
A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju
Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola
Medical Diagnostics & Life Sciences - Zarak Khurshid - Caris & Company, Inc.
September 14, 2009
INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008
Joseph Galli - Haemacure Corporation (hae:tsx)
April 16, 2007
SOFTWARE COMPANIES & SECURITY PRODUCTS - WALTER PRITCHARD - COWEN & COMPANY, LLC
December 11, 2006
ALTERNATIVE ENERGY & COAL: ELIZABETH COLLINS - MORNINGSTAR INC
August 07, 2006
ROUNDTABLE FORUM: GAMING
July 10, 2006
David Wenner - B&g Foods Inc (bgf)
February 27, 2006
Alexander Dexne - Medigene Ag (mdgef)
October 26, 2004
OUTLOOK FOR BIOTECHNOLOGY: RENI BENJAMIN - RODMAN & RENSHAW
May 03, 2004
Fredric Price - Biomarin Pharmaceutical Inc (bmrn)
May 03, 2004
S.belgrad / L.starr - Janus Capital Group (jns)
June 23, 2003
Paul Averback - Nymox Pharmaceutical Corporation (nymx)
July 08, 2002
Stephen Sherwin - Cell Genesys Inc (cege)
June 02, 2002
Mark Chandler - Luminex Corporation (lmnx)
October 12, 2001
Stuart Collinson - Aurora Biosciences Corporation (absc)
May 07, 2001
Outlook For Managed Care Stocks: David Shove - Prudential Securities
April 02, 2001
High-yield Securities In Media: Bruce Cheen - First Union Securities
October 09, 2000
